Preoperative parenteral parecoxib, and follow-up oral valdecoxib reduce length of stay and improve quality of patient recovery after laparoscopic cholecystectomy surgery

Anesthesia and Analgesia

Volumn 98, Issue 6, 2004, Pages 1665-1673

  Gan, Tong J ^a   Joshi, Girish P ^a   Viscusi, Eugene ^a   Cheung, Raymond Y ^a   Dodge, William ^a   Fort, John G ^a   Chen, Connie ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; GLYCOPYRRONIUM BROMIDE; KETOROLAC; NEOSTIGMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARECOXIB; PLACEBO; SEVOFLURANE; VALDECOXIB;

ADULT; ARTICLE; CHOLECYSTECTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PAIN ASSESSMENT; PATIENT SATISFACTION; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE NAUSEA; POSTOPERATIVE VOMITING; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VOMITING;

EID: 2442691835     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000117001.44280.F3     Document Type: Article

References (36)

1. Joshi GP. Anesthesia for minimally invasive surgery. In: Joshi GP, ed. Laparoscopy, thorascopy and hysteroscopy. Anesthesiology Clinics of North America. Philadelphia: Saunders, 2001.
2. Lillemoe KD, Lin JW, Talamini MA, et al. Laparoscopic cholecystectomy as a "true" outpatient procedure: initial experience in 130 consecutive patients. J Gastrointest Surg 1999;3:44-9.
3. Chung F, Mezei G. Factors contributing to a prolonged stay after ambulatory surgery. Anesth Analg 1999;89:1352-9.
4. Pavlin DJ, Rapp SE, Polissar NL, et al. Factors affecting discharge time in adult outpatients. Anesth Analg 1998;87:816-26.
5. Waddle JP, Evers AS, Piccirillo JF. Postanesthesia care unit length of stay: quantifying and assessing dependent factors. Anesth Analg 1998;87:628-33.
6. Bisgaard T, Kehlet H, Rosenberg J. Pain and convalescence after laparoscopic cholecystectomy. Eur J Surg 2001;167:84-96.
7. Sinclair DR, Chung F, Mezei G. Can postoperative nausea and vomiting be predicted? Anesthesiology 1999;91:109-18.
8. Wheeler M, Oderda G, Ashburn M, Lipman A. Adverse events associated with postoperative opioid analgesia: a systematic review. J Pain 2002;3:159-80.
9. Bisgaard T, Klarskov B, Kristiansen VB, et al. Multi-regional local anesthetic infiltration during laparoscopic cholecystectomy in patients receiving prophylactic multi-modal analgesia: a randomized, double-blinded, placebo-controlled study. Anesth Analg 1999;89:1017-24.
10. Joshi G. Pain management after ambulatory surgery. Ambul Surg 1999;7:3-12.
11. Joshi G. Fast tracking in outpatient surgery. Curr Opin Anaesthesiol 2001;14:635-9.
12. Noveck RJ, Laurent A, Kuss M, et al. Parecoxib sodium does not impair platelet function in healthy elderly and non-elderly individuals. Clin Drug Invest 2001;21:465-76.
13. Stoltz RR, Harris SI, Kuss ME, et al. Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects. Am J Gastroenterol 2002;97:65-71.
14. Camu F, Beecher T, Recker DP, Verburg KM. Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty. Am J Ther 2002;9:43-51.
15. Hubbard RC, Naumann TM, Traylor L, Dhadda S. Parecoxib sodium has opioid-sparing effects in patients undergoing total knee arthroplasty under spinal anaesthesia. Br J Anaesth 2003;90:166-72.
16. Leese PT, Talwalker S, Kent JD, Recker DP. Valdecoxib does not impair platelet function. Am J Emerg Med 2002;20:275-81.
17. Joshi G, Viscusi E, Gan TJ, et al. Effective treatment of laparoscopic cholecystectomy pain with intravenous followed by oral COX-2 specific inhibitor. Anesth Analg 2004;98:336-42.
18. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983;17:197-210.
19. Chang DJ, Fricke JR, Bird SR, et al. Rofecoxib versus codeine/acetaminophen in postoperative dental pain: a double-blind, randomized, placebo- and active comparator-controlled clinical trial. Clin Ther 2001;23:1446-55.
20. Daniels SE, Desjardins PJ, Talwalker S, et al. The analgesic efficacy of valdecoxib vs oxycodone/acetaminophen after oral surgery. J Am Dent Assoc 2002;133:611-21.
21. Gimbel JS, Brugger A, Zhao W, et al. Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults. Clin Ther 2001;23:228-41.
22. Barton SF, Langeland FF, Snabes MC, et al. Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery. Anesthesiology 2002;97:306-14.
23. Malan TP, Gordon S, Traylor L, et al. Parecoxib sodium 40 mg IM is an effective as morphine 12 mg IM following gynecologic laparotomy [abstract]. Eur J Anaesthesiol 2003;20(Suppl 30):A725.
24. Shang A, Gan T. Optimising postoperative pain management in the ambulatory patient. Drugs 2003;63:855-67.
25. Macario A, Glenn D, Dexter F. What can the postanesthesia care unit manager do to decrease costs in the postanesthesia care unit? J Perianesth Nurs 1999;14:284-93.
26. Gan T, Sloan F, Dear GL, et al. How much are patients willing to pay to avoid postoperative nausea and vomiting? Anesth Analg 2001;92:393-400.
27. Oderda GM, Evans RS, Lloyd J, et al. Cost of opioid-related adverse drug events in surgical patients. J Pain Symptom Manage 2003;25:276-83.
28. Fleisher LA, Yee K, Lillemoe KD, et al. Is outpatient laparoscopic cholecystectomy safe and cost-effective? A model to study transition of care. Anesthesiology 1999;90:1746-55.
29. Kissin I. Preemptive analgesia: why its effect is not always obvious. Anesthesiology 1996;84:1015-9.
30. Wu CL, Berenholtz SM, Pronovost PJ, Fleisher LA. Systematic review and analysis of postdischarge symptoms after outpatient surgery. Anesthesiology 2002;96:994-1003.
31. Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg 2003;97:534-40.
32. Ketorolac [package insert]. North Chicago, IL: Abbott Laboratories, 1999. Facts and Comparisons 2000:836-48.
33. Ketorolac [package insert]. North Chicago, IL: Abbott Laboratories, 1999. Facts and Comparisons 2000:836-48.
34. Schafer AI. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol 1995;35:209-19.
35. Agrawal A, Gerson CR, Seligman I, Dsida RM. Postoperative hemorrhage after tonsillectomy: use of ketorolac tromethamine. Otolaryngol Head Neck Surg 1999;120:335-9.
36. Strom BL, Berlin JA, Kinman JL, et al. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding: a postmarketing surveillance study. JAMA 1996;275:376-82.